Publications
182
Citations
5,973
Est. group size
~7
Recurring co-author estimate
Active years
23
Publishing since 2003
Typically publishes in teams of ~6 · 13% small-team papers (≤3 authors) · across 23 venues
- Developing the <scp>FIGO</scp> ‐ <scp>IPPS</scp> “R U <scp>MOVVING SOMe</scp> ” classification system for female chronic pelvic pain
International Journal of Gynecology & Obstetrics · 2025
- Does interdisciplinary group care for the treatment of endometriosis improve pain interference: protocol for a pilot randomised controlled trial at an urban academic medical centre
BMJ Open · 2025
- Female Dyspareunia and the Relationship to Neurophysiologic Mechanisms: A Scoping Review
Journal of Minimally Invasive Gynecology · 2025
- Early‐Life Exposures and Odds of Adenomyosis: A Population‐Based Case–Control Study
Paediatric and Perinatal Epidemiology · 2025
- Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study
Human Reproduction · 2024
- Impact of relugolix combination therapy on functioning and quality of life in women with endometriosis-associated pain
Fertility and Sterility · 2024
- An Analysis of Opioid Consumption and Patient Recovery after Hysterectomy by Surgical Approach
Journal of Women s Health · 2024
- From Dismissal to Solutions
Obstetrics and Gynecology · 2024
- A Plain Language Summary to Learn About Relugolix Combination Therapy for the Treatment of Pain Associated with Endometriosis
Pain Management · 2023
- 10095 Factors Associated with Racial Disparities in Postoperative Complications Following Hysterectomy
Journal of Minimally Invasive Gynecology · 2023
- Bleeding Patterns With Relugolix Combination Therapy in Women With Endometriosis-Associated Pain [ID: 1345374]
Obstetrics and Gynecology · 2023
- O-032 Effect of relugolix combination therapy in women with endometriosis-associated pain who received prior first-line hormonal treatment: SPIRIT 1 and 2
Human Reproduction · 2023
- Impact of Time Since Surgical Diagnosis of Endometriosis on Outcomes with Relugolix Combination Therapy: Spirit Long-Term Extension (LTE)
Journal of Minimally Invasive Gynecology · 2023
- Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)
The Lancet · 2022
- Development of the Bleeding and Pelvic Discomfort Scale for Use in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Value in Health · 2022
- Journal of Minimally Invasive Gynecology×32
- Obstetrics and Gynecology×12
- American Journal of Obstetrics and Gynecology×10
- Fertility and Sterility×7
- Obstetrical & Gynecological Survey×5
- Sara R. Till
Medicine · University of Michigan
- SR Till
Medicine · University of Michigan
- Stacey A. Missmer
Medicine · University of Michigan
- Amina Tanweer
Medicine · University of Michigan
- Mark Hoffman
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile